Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
Open-market buys, last 90 days
$20,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Verjee Rehan +$20K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-11-02 Bensen Daniel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +83,626 83,626
2021-11-02 Bensen Daniel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Bensen Daniel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Harris Todd Chief Executive Officer Grant or award · Stock Option (Right to Buy) +215,038 215,038
2021-11-02 Harris Todd Chief Executive Officer Grant or award · Stock Option (Right to Buy) +25,884 25,884
2021-11-02 Harris Todd Chief Executive Officer Grant or award · Stock Option (Right to Buy) +25,884 25,884
2021-09-17 Cormorant Asset Management, LP Former 10% Owner Conversion +757,432 757,432
2021-09-17 Cormorant Asset Management, LP Former 10% Owner Purchase +312,500 $16.00 $5.0M 1,069,932
2021-09-17 Cormorant Asset Management, LP Former 10% Owner Conversion · Series B Convertible Preferred Stock −757,432 0
2021-09-17 Kjellson Nina S Director Conversion +3,936,595 3,936,595
2021-09-17 Kjellson Nina S Director Conversion +473,396 473,396
2021-09-17 Kjellson Nina S Director Conversion · Series A Preferred Stock −1,333,334 0
2021-09-17 Kjellson Nina S Director Conversion · Series B Preferred Stock −182,257 0
2021-09-17 Kjellson Nina S Director Conversion · Series B Preferred Stock −182,258 0
2021-09-17 Canaan XI L.P. 10% owner Conversion +3,936,595 3,936,595
2021-09-17 Canaan XI L.P. 10% owner Conversion +473,396 473,396
2021-09-17 Canaan XI L.P. 10% owner Conversion · Series A Preferred Stock −1,333,334 0
2021-09-17 Canaan XI L.P. 10% owner Conversion · Series B Preferred Stock −182,257 0
2021-09-17 Canaan XI L.P. 10% owner Conversion · Series B Preferred Stock −182,258 0
2021-09-17 RA CAPITAL MANAGEMENT, L.P. Director Conversion +4,047,120 4,047,120

Page 19 of 21 · 417 trades